Pardeep Nijhawan Medicine Professional Corp, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 2,000 shares at $2.99 ($6K) on 2022-03-31, disclosed to the SEC on 2022-04-01.
Open-market purchase of $6k EDSA by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| EDSA | BUY | 2020-05-28 | $9K | — | Filing → |
| EDSA | BUY | 2020-03-19 | $7K | — | Filing → |